Immune checkpoint inhibitor target found to promote skin cancer growth

Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer.

STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023 – Biotech Investments

EQS-News: STRATEC SE / Key word(s): Quarter Results STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023 27.10.2023 / 06:55 CET/CEST The issuer is solely

October 28, 2023

What you need to know about the drug price fight in those TV ads

In recent months ominous ads about prescription drugs have flooded the TV airwaves. Perhaps by design, it’s not always clear who’s sponsoring the ads or

July 10, 2023

For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission

SAN DIEGO — Brian Koffman found himself in a situation a couple years ago that most chronic lymphocytic leukemia patients eventually do: relapse. The expectation

December 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.